^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Descartes-08

    i
    Other names: Descartes-08, anti-BCMA chimeric antigen receptor T cell therapy
    Associations
    News
    Trials
    Company:
    Cartesian Therap
    Drug class:
    BCMA-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials